Cannabis Strategic Ventures (OTC: NUGS) this morning announced a major common share restructuring. The company has cancelled a total of 75.6 million shares, including 20 million from the company’s chief executive officer Simon Yu. The move to cancel approximately 25% of the total shares is intended to raise shareholder value and build long-term value for all. The restructuring follows the company’s recently announced partnerships with Fitamins and Asher House Pet CBD, both of which operate in the multi-million dollar CBD products market. “The future of Cannabis Strategic Ventures is all about acquiring and partnering with the best brands in the fast-growing cannabis marketplace. The streamlined share structure will continue to make our company an attractive partner as we work toward signing other similar brands and distribution partnerships,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release.
To view the full press release, visit http://ibn.fm/wjMUk
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
